Stock-Based Compensation, Stock Option Activity (Details) - USD ($)		3 Months Ended					12 Months Ended
	Dec. 30, 2022	Dec. 31, 2023	Jun. 30, 2023	Dec. 31, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
Unamortized Stock Compensation Expense [Abstract]
Shares issued for consulting services (in shares)	378,787
Weighted-average grant date fair value, granted (in dollars per share)							$ 9.59	$ 4.4
Common Stock [Member]
Number of Shares [Roll Forward]
Exercised (in shares)		(80,526)	(1,409)	(269,535)	(7,794)	(2,282)
Unamortized Stock Compensation Expense [Abstract]
Shares issued for consulting services (in shares)		100,000	100,000	378,787			200,000
Stock Options [Member]
Number of Shares [Roll Forward]
Options outstanding, beginning balance (in shares)							4,171,311
Granted (in shares)							1,414,000
Exercised (in shares)							(81,935)
Forfeited (in shares)							(456,405)
Expired (in shares)							(17,626)
Options outstanding, ending balance (in shares)		5,029,345		4,171,311			5,029,345	4,171,311
Vested and expected to vest (in shares)		5,029,345					5,029,345
Exercisable (in shares)		2,829,330					2,829,330
Weighted Average Exercise Price [Roll Forward]
Options outstanding, beginning balance (in dollars per share)							$ 5.56
Granted (in dollars per share)							10.31
Exercised (in dollars per share)							3.77
Forfeited (in dollars per share)							10.64
Expired (in dollars per share)							16.17
Options outstanding, ending balance (in dollars per share)		$ 6.43		$ 5.56			6.43	$ 5.56
Vested and expected to vest (in dollars per share)		6.43					6.43
Exercisable (in dollars per share)		$ 5.6					$ 5.6
Weighted Average Remaining Contractual Life and Aggregate Intrinsic Value [Abstract]
Options outstanding, weighted average remaining contractual life							7 years 5 months 1 day	7 years 10 months 20 days
Granted, weighted average remaining contractual life							9 years 2 months 4 days
Vested and expected to vest, weighted average contractual life							7 years 5 months 1 day
Exercisable, weighted average contractual life							6 years 6 months 10 days
Options outstanding, aggregate intrinsic value							$ 32,779,920
Granted, aggregate intrinsic value							290
Exercised, aggregate intrinsic value							0
Forfeited, aggregate intrinsic value							0
Options outstanding, aggregate intrinsic value		$ 4,395,227		$ 32,779,920			4,395,227	$ 32,779,920
Vested and expected to vest, aggregate intrinsic value		4,395,227					4,395,227
Exercisable, aggregate intrinsic value		3,315,101					3,315,101
Unamortized Stock Compensation Expense [Abstract]
Unamortized stock compensation expense		$ 13,950,484					$ 13,950,484
Period for recognition							2 years 5 months 19 days
Weighted-average grant date fair value, granted (in dollars per share)							$ 9.59